<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Carrico AW</submitter><funding>NIMH</funding><funding>NIDA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NIDA</funding><funding>NIAID</funding><pagination>151-158</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11269022</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>This epigenomics sub-study embedded within a randomized controlled trial examined whether an evidenced-based behavioral intervention model that decreased stimulant use altered leukocyte DNA methylation (DNAm).&lt;h4>Methods&lt;/h4>Sexual minority men with HIV who use methamphetamine were randomized to a five-session positive affect intervention (n = 32) or an attention-control condition (n = 21), both delivered during three months of contingency management for stimulant abstinence. All participants exhibited sustained HIV virologic control - an HIV viral load less than 40 copies/mL at baseline and six months post-randomization. The Illumina EPIC BeadChip measured leukocyte methylation of cytosine-phosphate-guanosine (CpG) sites mapping onto five a priori candidate genes of inte</pubmed_abstract><journal>Brain, behavior, and immunity</journal><pubmed_title>A positive affect intervention alters leukocyte DNA methylation in sexual minority men with HIV who use methamphetamine.</pubmed_title><pmcid>PMC11269022</pmcid><funding_grant_id>K24-MH093225</funding_grant_id><funding_grant_id>K24 DA057874</funding_grant_id><funding_grant_id>P30 AI073961</funding_grant_id><funding_grant_id>K23-DA039800</funding_grant_id><funding_grant_id>P30 AI027763</funding_grant_id><funding_grant_id>K24 MH093225</funding_grant_id><funding_grant_id>R01 DA058437</funding_grant_id><funding_grant_id>R01 DA033854</funding_grant_id><funding_grant_id>R01-DA033854</funding_grant_id><funding_grant_id>K23 DA039800</funding_grant_id><pubmed_authors>Moskowitz JT</pubmed_authors><pubmed_authors>Asam K</pubmed_authors><pubmed_authors>Ghanooni D</pubmed_authors><pubmed_authors>Aouizerat BE</pubmed_authors><pubmed_authors>Gouse H</pubmed_authors><pubmed_authors>Cherenack EM</pubmed_authors><pubmed_authors>Dilworth SE</pubmed_authors><pubmed_authors>Paul RH</pubmed_authors><pubmed_authors>Flentje A</pubmed_authors><pubmed_authors>Rubin LH</pubmed_authors><pubmed_authors>Neilands TB</pubmed_authors><pubmed_authors>Carrico AW</pubmed_authors><pubmed_authors>Fuchs D</pubmed_authors><pubmed_authors>Chavez JV</pubmed_authors></additional><is_claimable>false</is_claimable><name>A positive affect intervention alters leukocyte DNA methylation in sexual minority men with HIV who use methamphetamine.</name><description>&lt;h4>Objective&lt;/h4>This epigenomics sub-study embedded within a randomized controlled trial examined whether an evidenced-based behavioral intervention model that decreased stimulant use altered leukocyte DNA methylation (DNAm).&lt;h4>Methods&lt;/h4>Sexual minority men with HIV who use methamphetamine were randomized to a five-session positive affect intervention (n = 32) or an attention-control condition (n = 21), both delivered during three months of contingency management for stimulant abstinence. All participants exhibited sustained HIV virologic control - an HIV viral load less than 40 copies/mL at baseline and six months post-randomization. The Illumina EPIC BeadChip measured leukocyte methylation of cytosine-phosphate-guanosine (CpG) sites mapping onto five a priori candidate genes of inte</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-03-18T13:30:01.005Z</modification><creation>2025-08-18T09:54:17.984Z</creation></dates><accession>S-EPMC11269022</accession><cross_references><pubmed>38777283</pubmed><doi>10.1016/j.bbi.2024.05.025</doi></cross_references></HashMap>